Open original FDA record ↗Recall record
- FDA identifier
- Z-1570-2011
- Company in FDA record
- Covidien LP
- FDA classification date
- Mar 7, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The heparin sodium USP used to manufacture blood collection tubes was produced with crude heparin containing Over-Sulfated Chondroitin Sulfate.
Source facts
- Action
- Covidien sent an URGENT PRODUCT RECALL letter dated November 12, 2010, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to immediately stop using the product, and return it to the firm. Distributors were instructed to notify their customers. All customers were required to respond to the notice regardless of their remaining inventory. Responses will be tracked for follow-up and effectiveness checks. For Customers Service questions regarding this recall call 1-800-962-9888 option 1.
- Initiated
- 2010-11-15
- Root cause
- Material/Component Contamination
- Terminated
- 2015-12-04
- Distribution
- Worldwide Distribution - USA including AL, AZ, CA, CO, DE, FL, GA, IA, ID, IL, KS, KY, MA, MI, MN, MO, MS, NC, ND, NE, NJ, NM, MV, MY, OH, OK, PA, SC, SD, TN, TX, WA, and WI and the country of Canada
- Recall number
- Z-1570-2011
- Recall status
- Terminated
- CDRH record ID
- 95823
- FDA classified
- 2011-03-07
- Recall event number
- 57314